Breast, cervical, and lung cancer: A comparison of real healthcare costs and INA-CBGs rates in the era of national health insurance.
Fitriana YuliastutiTri Murti AndayaniDwi EndartiSusi Ari KristinaPublished in: Pharmacy practice (2022)
Although statistical evaluation showed a significant difference for some cases and not significant for other cases, in real conditions, there is a difference between the INA-CBGs and the real costs that must be evaluated by the government and stakeholders to provide justice for cancer patients.